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Abstract
BACKGROUND—Fetal alcohol spectrum disorder (FASD) describes a range of birth defects 
including various congenital heart defects (CHDs). Mechanisms of FASD-associated CHDs are 
not understood. Whether alcohol interferes with a single critical event or with multiple events in 
heart formation is not known.
RESULTS—Our zebrafish embryo experiments showed that ethanol interrupts different cardiac 
regulatory networks and perturbed multiple steps of cardiogenesis (specification, myocardial 
migration, looping, chamber morphogenesis and endocardial cushion formation). Ethanol 
exposure during gastrulation until cardiac specification or during myocardial midline migration 
did not produce severe or persistent heart development defects. However, exposure comprising 
gastrulation until myocardial precursor midline fusion or during heart patterning stages produced 
aberrant heart looping and defective endocardial cushions. Continuous exposure during entire 
cardiogenesis produced complex cardiac defects leading to severely defective myocardium, 
endocardium, and endocardial cushions. Supplementation of retinoic acid with ethanol partially 
rescued early heart developmental defects, but the endocardial cushions did not form correctly. In 
contrast, supplementation of folic acid rescued normal heart development, including the 
endocardial cushions.
CONCLUSIONS—Our results indicate that ethanol exposure interrupted divergent cardiac 
morphogenesis events causing heart defects. Folic acid supplementation was effective in 
preventing a wide spectrum of ethanol-induced heart developmental defects.
INTRODUCTION
Fetal Alcohol Spectrum Disorder (FASD), as a clinical entity, is associated with maternal 
alcohol consumption, producing a specific birth defect spectrum. Prenatal ethanol exposure 
causes central nervous system, craniofacial and body growth defects, and disrupts various 
organogenesis pathways, including heart. Babies born with FASD display various congenital 
heart defects (CHDs), which includes ventricular and/or atrial septal defects and conotruncal 
defects. It is unknown how alcohol consumption produces a wide spectrum of CHDs. This 
may be due to differences in timing (cardiogenic stage-dependent and/or duration 
dependent) and doses of alcohol exposure during heart morphogenesis. Among all FASD 
related CHDs, septal defects are the most frequently diagnosed anomalies (Burd et al., 
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2007). Ethanol exposures produce cardiac defects in animal models that are similar to 
human patients. In chick, acute ethanol administration at HH stage 18 (cardiac septation 
period) resulted in cardiac malformations, including ventricular septal defect (VSD) and 
overriding aorta (Fang et al., 1987). Alcohol induced VSDs occurred in chick embryos in a 
strain dependent way (Bruyere and Stith, 1993). In mice, Sulik and co-workers reported that 
acute ethanol exposure on gestational day (GD) 8 produced abnormal heart and defective 
great vessel formation (Daft et al., 1986). Alcohol exposure on GD 8, 9, 10 (somitogenesis 
period) in mice produced high incidence of VSDs, but exposure on day 7 (gastrulation) was 
resistant to the induction of heart defects (Webster et al., 1984). Recently, Linask and co-
workers used echocardiography to identify embryos with heart valve regurgitation and 
reported that intraperitoneal injection (like a binge-drinking dose) of ethanol in mice on 
embryonic day 6.75 (gastrulation) produced atrioventricular and semilunar valve defects. In 
another study, Cavieres and Smith failed to reproduce valvoseptal defects in three chicken 
strains after ethanol exposure either during gastrulation, somitogenesis, or cardiac septation 
period (Cavieres and Smith, 2000). Additional model organisms that reliably reproduce 
defects to study FASD-associated heart defects are required.
Externally fertilized, transparent zebrafish embryos expressing fluorescent protein in the 
developing myocardium or endocardium would be instrumental for the analyses of ethanol 
effects in live embryos. Recent identification of the second heart field (SHF) supports the 
premise that zebrafish is a suitable system to model human CHDs (Lazic and Scott, 2011; 
Zhou et al., 2011a). Zebrafish embryos exposed to ethanol exhibited short body, craniofacial 
defect and microphthalmia, the characteristic features of FASD (Blader and Strahle, 1998; 
Kashyap et al., 2011, Marrs et al., 2010). Based on histology and heart rate analyses, Dlugos 
and Rabin demonstrated that continuous ethanol exposure during zebrafish embryogenesis 
altered heart morphology and function (Dlugos and Rabin, 2010). In zebrafish, heart 
morphogenesis begins at 5 hours post fertilization (hpf) when cardiac progenitors form in 
ventral and lateral regions of the embryo. Cardiac precursors reach anterior lateral plate 
mesoderm (ALPM) at around 5-somite (5s) stage (~12 hpf) and start to express cardiac 
specific genes. At 20s stage (~19 hpf), myocardial precursors fuse and form the heart cone. 
The heart tube is formed at 24 hpf. Heart primordia complete rightward looping at 36 hpf, 
and two distinct chambers arise. Finally, endocardial cells at the chamber boundaries 
undergo an epithelial-to-mesenchymal transition and form cardiac cushions, occurring 
around 48 hpf, eventually producing heart valves (Stainier, 2001). These critical 
cardiogenesis events are highly evolutionarily conserved within vertebrates. Subtle 
perturbation of these processes can cause severe physiological defects. Acute ethanol 
exposure during individual heart development stages and immediate analysis of cardiogenic 
events will help us understand alcohol effects on individual developmental events. 
Analyzing later stages will determine whether heart defects persist.
Various proposed mechanisms fail to completely explain the teratogenic effects of ethanol. 
Epidemiological studies showed that FASD incidence is higher in infants born to lower 
socioeconomic status alcoholic mothers compared to infants born to middle class alcoholics 
(Abel, 1995; Abel and Hannigan, 1995; Bingol et al., 1987). Lower socioeconomic 
population is at a greater risk for poor nutrition. Alcohol consumption also aggravates 
malnutrition by interfering with a person’s ability to absorb and use the nutrients they 
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consume, making the nutrient pool less than optimal for supporting fetal growth in alcoholic 
mothers (Abel and Hannigan, 1995). Alcoholics tend to have deficiencies in certain 
vitamins, including vitamin A and folic acid (FA) (Lieber, 2003). Vitamin A can be 
metabolized to retinoic acid (RA), which is essential for normal development, including 
heart. RA signaling plays multiple roles during cardiogenesis, including cardiac 
specification, anterior-posterior patterning, left-right specification, defining the limit of the 
second heart field, endocardial cushion formation and heart chamber growth (Hochgreb et 
al., 2003; Keegan et al., 2005; Ryckebusch et al., 2008; Sirbu et al., 2008; Waxman et al., 
2008; Xavier-Neto et al., 2001). Many investigators hypothesized that abnormalities 
observed in FASD are caused by competitive inhibition of alcohol dehydrogenase catalyzed 
retinol oxidation by ethanol in the embryo, decreasing RA levels and signaling (Duester, 
1991; Marrs et al., 2010; Yelin et al., 2005). Yelin et al. showed that ethanol exposure 
reduced the expression of hox genes in the Xenopus embryos, which are targets of RA 
signaling. Ethanol treatment rescued the effects of exposure to high levels of vitamin A 
(Yelin et al., 2005). Sulik and colleagues showed that ethanol treatment suppressed the 
expression of early limb genes in mice that could be phenocopied using an inhibitor that 
specifically blocks retinoid X receptor transcription factors (RXR, RA receptors) (Johnson 
et al., 2007). Another vitamin, folic acid, is essential for the synthesis, repair and regulation 
of DNA. FA is particularly important during rapid growth of the developing embryo. Studies 
showed that ethanol directly inhibits folate metabolism in cells and folate transport into cells 
(Ballard et al., 2012; Hamid and Kaur, 2007). A recent study demonstrated that FA transport 
to the fetus was impaired in pregnancies with chronic alcohol exposure (Hutson et al., 2012). 
Alcohol ingestion by animals inhibits folate-dependent DNA methylation (Ballard et al., 
2012). Using mouse and avian models, Linask and co-workers showed that FA 
supplementation prevented ethanol-induced heart defects (Serrano et al., 2010). 
Epidemiologic studies showed that severe congenital heart defect prevalence was 
significantly reduced by prenatal FA fortification (Bailey and Berry, 2005; Ionescu-Ittu et 
al., 2009). These findings suggests that supplementation of essential nutrients may reduce 
the risk of CHD associated with FASD.
Aims of the present study were to examine the utility of the zebrafish as a model system to 
study FASD-associated CHDs, examine the ethanol effect on distinct cardiogenic events to 
determine whether heart developmental stages were differentially sensitive to ethanol in 
producing persistent heart defects. The effects of dosage and duration of ethanol exposure 
on heart development were also tested. Additionally, RA and FA were tested for their ability 
to prevent ethanol-induced cardiac defects in zebrafish.
RESULTS
Ethanol effects were analyzed using various assays, including live imaging of transgenic 
zebrafish lines Tg[cmlc2:GFP], expressing GFP in myocardial cells, and Tg[fli1:EGFP], 
expressing GFP in endothelial and endocardial cells.
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Chronic ethanol exposure during embryogenesis severely disrupts heart morphogenesis
To model chronic ethanol exposure, embryos were exposed to ethanol from 2 to 48 hpf (Fig. 
1A). Development of the heart was analyzed at 48, 52, 72 and 96 hpf. Ethanol exposed 
embryos displayed pericardial edema (Fig. 1B), aberrantly looped/straight heart at 48 hpf, 
which was worse at 72 hpf (Fig. 1 C, K). A small fraction of embryos also exhibited cardia 
bifida (Figs. 1K and 2D). These embryos never recovered, displaying severe cardiac defects 
including pericardial blood clot at 96 hpf (Fig. 1I, J). Examination of control 
Tg[cmlc2:GFP] embryos showed bean shaped atrium and ventricle closely apposed to each 
other with a narrow atrioventricular (AV) canal. Ethanol treated embryos showed smaller, 
misshapen myocardial chambers with a wider AV canal (Fig. 1D, Supp. Movies S1–S4). 
These embryos also displayed uneven ventricular wall and often had double lobed ventricle 
along the left/right axis, at higher frequency with 150 mM ethanol treatment (Fig. 1E, F, J, 
Supp. Movies S1–S4). To analyze ventricular defects in detail, cardiomyocyte numbers were 
counted at 52 hpf. Ethanol treatment reduced ventricular cardiomyocytes (VC) in a dose 
dependent way (control, VC=112±5; ethanol-100mM, VC=83±5; ethanol-150mM, 
VC=66±4 cells, P< 0.008). To understand ventricular wall defect cardiomyocyte 
morphology was assessed with alcam antibody staining, an adhesion protein expressed at 
embryonic myocardium cell-cell borders. Zebrafish ventricular cardiomyocytes dramatically 
change shape in a regionally confined manner during chamber growth, from 48–58 hpf 
(Auman et al., 2007). Distinct cardiomyocyte shape changes occur in the three major regions 
of the cardiac wall, outer curvature (OC), inner curvature (IC), and AV canal. Initially small, 
round cardiomyocytes in the heart tube undergo cell shape changes, producing large, 
elongated cardiomyocytes in the OC and AV region, but IC cardiomyocytes remain round 
and small (Auman et al., 2007). Control embryo heart showed these cell shapes (Mean 
surface area, OC=124±27 μm2; IC=73±19.μm2; Fig. 2B). Regional confinement of similar 
shaped cardiomyocyte was hard to distinguish and alignment of cells was highly 
disorganized after ethanol exposure (Fig. 2C). Although, 100mM ethanol treated embryos 
displayed elongated cells in the OC region (Mean surface area of elongated cells, 86±26 
μm2), circular cells were often found close to elongated cells. A few thin, elongated 
cardiomyocytes were present in the mid-region of the ventricular wall in ethanol exposed 
embryos with double lobed ventricles (Fig. 2C). Cell shape change was rare in 150 mM 
ethanol treated embryos (Mean surface area, 37 μm2±30). Alcam staining also showed 
cardia bifida in ethanol treated embryos (Fig. 2D).
Examining live Tg[fli1:EGFP] embryos at 48 and 72hpf showed misshapen endocardium in 
ethanol treated individuals (Fig. 1G). Texas red-phalloidin stained (detecting F-actin) 
Tg[fli1:EGFP] embryos showed that endocardial lining corresponded to the shape of the 
myocardial layer (Fig. 1H). Endocardial cushions, precursor of heart valves, form at the AV 
canal by endocardial cells epithelial-to-mesenchymal transformation, where differentiated 
endocardial cells delaminate, invade and cellularize the extracellular matrix between 
myocradium and endocardium (Staudt and Stainier, 2012). Differentiated endocardial cells 
(cushion forming cells) express high levels of F-actin (Bartman et al., 2004; Beis et al., 
2005). Endocardial cushion formation was analyzed in the Tg[fli1:EGFP] embryos at 52 hpf 
by Texas red-phalloidin staining. Control embryos showed a cluster of GFP and F-actin 
positive cuboidal shaped cells at the AV boundary, but ethanol treated embryos displayed 
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fewer or no clustered GFP and F-actin positive cells at the AV boundary (Fig. 2E–G). 
Together, these results indicate that ethanol exposure during all cardiogenesis stages 
severely disrupts myocardium, endocardium, and endocardial cushion morphogenesis. 
Higher concentrations of ethanol produce more severe phenotypes.
Ethanol exposure during cardiac specification perturbs cardiac gene expression, but heart 
defects do not persist
To determine whether ethanol exposure during initial stages of cardiogenesis, gastrulation 
until cardiac specification, produces heart defects at later stages, embryos were treated with 
ethanol from 2 hpf to 12s stage (Fig. 3A). Ethanol exposure caused a developmental delay. 
Control embryos reached 12s at 15 hpf; 100 mM ethanol treated embryos reached 12s at 
15.5 hpf; and 150 mM ethanol treated embryos reached 12s around 15.75 hpf. Thus, somite 
numbers (hpf, corresponding developmental timing of control embryos) were used to match 
similar developmental stages instead of developmental time at early stages.
Expression patterns of myocardial induction gene fgf8a and cardiogenic transcription factors 
nkx2.5 and gata5 were examined at 13s (15.5 hpf) stage by in situ hybridization (ISH). ISH 
results showed moderate expansion of these expression domains in the ALPM region in 
ethanol treated embryos compared to controls (Fig. 3B–D). Quantitative PCR was used to 
examine early transcription factors required for heart formation at 6s (12 hpf) and 12s (15 
hpf) stages. The expression of gata5 and hand2 showed significant upregulation after 
ethanol treatment at 12s (Fig. 3E). However, transcript levels of other cardiogenic genes 
tested did not show significant changes (Fig. 3E). Cardiac cone formation was analyzed at 
20s stage (19 hpf) using cardiac myosin light chain (cmlc2) ISH. Myocardial cells in 20s 
control embryos migrated from the ALPM to the midline and fused to form the heart cone. 
In 100 mM ethanol exposed 20s embryos, only posterior fusion of myocardial cells was 
observed, and 150 mM ethanol treated 20s embryos exhibited two separate, unfused rows of 
myocardial precursors (Fig. 3F, I). Interestingly, these embryos showed relatively normal 
hearts at 36 and 60 hpf, with normal cardiac looping and heart chambers (Fig. 3G). Similar 
to myocardial cells, examination of Tg[fli1:EGFP]embryos at 19s stage showed delayed 
fusion of endocardial cells in the ethanol exposed embryos; those embryos exhibited near 
normal endocardium at 44 hpf (Sarmah and Marrs, unpublished observations).
To examine whether early ethanol exposure affects endocardial cushion formation, bmp4 
ISH was performed at 48 hpf. The expression of bmp4 was prominent in the AV canal and 
outflow tract (OFT) in the control embryos. Ethanol exposed embryos exhibited bmp4 
expression pattern that was indistinguishable from control embryos (Fig. 3H). Taken 
together, these results show that ethanol exposure during cardiac specification expands 
cardiogenic gene expression domain in the embryo and delays myocardial cone formation. 
Embryos recover from this developmental delay and show no detectable, persistent cardiac 
defects.
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Ethanol exposure until cardiac fusion stage produces persistent heart developmental 
defects
To determine whether ethanol exposure for a longer time period (gastrulation until 
myocardial midline fusion) produces persistent heart defects, embryos were ethanol treated 
from 2 hpf to 20s stage (Fig. 4A). ISH to detect cmlc2 and ventricle myosin heavy chain 
(vmhc) expression revealed that ethanol exposure significantly delayed myocardial cone 
formation. By 19s (18.5 hpf) stage, myocardial precursors fused posteriorly in control 
embryos (99%, n=60), but myocardial precursors in 100 mM ethanol exposed embryos 
remained separated (97%, n=65) (Fig. 4B). The cone formation delay was more severe in 
150 mM ethanol treated embryos, displaying two widely separated rows of myocardial 
precursors (100%, n=59) (Fig. 4B). Mantel-Haenszel chi-square tests revealed significant 
changes (P<0.0001) for both control vs. EtOH-100 and control vs. EtOH-150. Delayed 
posterior fusions of myocardial cells were visible until around 25s stage (Fig. 4C, D).
Similar to myocardial cells, bilateral endocardial precursors originate at ALPM, migrate to 
the midline and fuse. Ethanol exposed (2 hpf to 20s) Tg[fli1:EGFP] embryos showed 
delayed fusion of endocardial precursors at 20s stage (Fig. 4G). Endocardial lining (at 24 
hpf; Fig. 4H) was abnormal, perhaps corresponding to the heart tube defect.
In utero alcohol exposure reportedly alters directional asymmetry in patients’ faces 
(Klingenberg et al., 2010) and left-right dominance in the frontal brain lobe (Riikonen et al., 
1999). To examine whether ethanol exposure (2 hpf to 20s) altered cardiac asymmetry or 
caused cardia bifida, bmp4 expression was analyzed by ISH. At 20 hpf, bmp4 was 
predominantly expressed on the left side of the heart field in the control embryos (Fig. 4E). 
Ethanol exposed 20 hpf embryos displayed an expression pattern similar to the bmp4 
expression in the younger embryos (14–19s; Thisse, 2005) (Fig. 4E′), showing a 
developmental delay. At around 25 hpf, when control embryos displayed bmp4 expression 
in the linear heart tube, ethanol treated embryos exhibited asymmetric bmp4 expression 
similar to the control embryos at 20 hpf (Fig. 4F–F‴). Higher bmp4 expression on the left 
side of the ethanol exposed heart indicating delayed establishment of normal cardiac 
asymmetry.
To measure early ethanol exposure effects (2 hpf to 20s) on heart development, cardiac 
looping angles were measured in Tg[cmlc2:GFP]embryos at 36 hpf and 60 hpf. The 
“looping angle” was defined as the angle between the antero-posterior axis of the embryo 
and the plane of the atrioventricular junction (Chernyavskaya et al., 2012). Ethanol exposed 
embryos exhibited reduced looping, producing significantly greater average looping angle 
than control embryos (Fig. 4I, J).
Endocardial cushion formation was defective after early ethanol exposure. Unlike control 
embryos where bmp4 expression was prominent in the AV boundary and OFT, ethanol 
exposed embryos displayed strong ectopic expression of bmp4 throughout the ventricle at 48 
hpf (Fig. 4K). Accordingly, Tg[fli1:EGFP] and F-actin positive cells, that were clustered at 
the AV boundary in the control embryos, were dispersed in the ventricle in the ethanol 
exposed embryos at 52 hpf (Fig. 4L, M).
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These experiments raise two possibilities: (i) the observed cardiac defects were due to 
cumulative ethanol exposure during gastrulation through midline fusion (2 hpf–20s); or (ii) 
due to ethanol exposure only during the myocardial migration event (12s–20s). To 
investigate that possibility, embryos were treated with ethanol from 12s to 20s stage and 
cmlc2 expression was examined at 20s stage (Fig. 4N). A slight delay in myocardial 
migration was detected between the control and ethanol treated embryos (Fig. 4O–R), 
indicating that more persistent, severe heart defects require ethanol exposure for a longer 
period.
Ethanol exposure during cardiac patterning caused heart morphogenesis and endocardial 
cushion defects
Effects of ethanol exposure during cardiac patterning (heart tube and loop formation) stages 
(20s until 36 hpf) was studied next (Fig. 5A). Ethanol exposure during cardiac patterning 
delayed cardiac looping, as revealed by cmlc2 ISH (Fig. 5B, C) and live imaging of 
Tg[cmlc2:GFP] embryos. Although the degree of looping was reduced, all ethanol treated 
embryos displayed rightward looping around 40 hpf as seen in fixed Tg[cmlc2:GFP] 
embryos. Cardiac chambers were smaller and elongated, and AV canals were defective in 
these embryos (Fig. 5D). Texas red-phalloidin stained ethanol exposed Tg[fli1:EGFP] 
embryos confirmed defective endocardial cushions, exhibiting GFP and F-actin positive 
cells throughout the ventricle, without evident clustering at the AV boundary (Fig. 5E; 
compare control panels Figs. 2E and 4L).
To determine whether ethanol exposure prior to cardiomyocyte shape change affects 
regionally confined cell shape changes, embryos were alcam stained at 40 and 52 hpf. At 40 
hpf, small, rounded cells were present throughout the ventricle wall in 150 mM ethanol 
exposed embryos, but elongated cells were apparent in the control and 100 mM ethanol 
treated embryos. At 52 hpf, ethanol exposed embryos exhibited surface area of OC 
cardiomyocytes similar to control OC cardiomyocytes [Mean surface area (OC): control, 
118±35 μm2; E-100mM, 108±30 μm2; 107±23 μm2; P value was not significant; Fig. 5F]. 
These findings indicate that ethanol exposure during cardiac patterning was detrimental, 
leading to heart valve and chamber morphology defects, however, regionally confined 
cardiomyocyte shape changes was not perturbed.
Ethanol exposure during chamber growth stage caused minor developmental perturbation
To determine whether ethanol affects cell shape changes during chamber morphogenesis 
(when zebrafish ventricular cardiomyocytes dramatically change shape) leads to ventricular 
wall defects, embryos were treated with ethanol from 40 to 56 hpf (Fig. 5G). Confocal 
imaging of Tg[cmlc2:GFP] embryos revealed slightly smaller but otherwise normal looking 
chambers in ethanol exposed embryos (Fig. 5H). Those embryos showed relatively normal 
cardiac looping angles (Fig. 5H). Alcam staining at 56 hpf showed few or no effects on 
cardiomyocyte shape changes comparing control and ethanol treated embryos (Fig. 5I). 
These findings show that ethanol exposure during cardiac growth had few effects on heart 
development.
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RA supplement partially restores ethanol-induced early cardiac defects, but A-V canal 
defects remain
It was previously shown that 1 nM RA supplement could rescue a spectrum of ethanol-
induced defects produced by 100 mM ethanol exposure in zebrafish without causing 
distinguishable RA induced defects (Marrs et al., 2010). Here, RA supplementation was 
tested for rescue of ethanol-induced cardiac defects. Co-supplementation of 1 nM RA with 
ethanol during cardiogenesis, from 2 to 48 hpf (Fig. 6A) rescued ethanol-induced small eye 
and body length defects (Fig. 6B–M). However, RA supplementation could not rescue heart 
edema (Fig. 6H–M). Although the chamber size was improved over ethanol treated 
embryos, RA plus ethanol treated embryos had either straight or reduced heart looping, and 
endocardial cushions were malformed (Fig. 6N–Y). However, unlike ethanol treated 
embryos (displaying fewer or no endocardial cushion cells), ethanol plus RA treated 
embryos showed endocardial cushion cells dispersed throughout the ventricle (Fig. 6T–Y). It 
was previously reported that 10 nM RA supplementation during HH stage ~8 (~26 hpf) to 
~48 hpf rescued ethanol-induced heart looping defect in quail embryo culture (Twal, 1997). 
Next, RA supplementation during different cardiogenic events were tested, which would test 
a less stringent requirement for rescue in a shorter developmental period. Contrary to the 
prolonged treatment, co-supplementation of RA with ethanol during early cardiac 
specification (2 hpf to 12s) significantly restored nkx2.5 expression and partially rescued 
myocardial migration delay (Fig. 7A–D). Myocardial migration delay was also partially 
rescued by co-treating embryos with RA and ethanol until myocardial fusion (2 hpf to 20s), 
as shown by cmlc2 ISH at 20s stage (Fig. 7E–G). However, embryos co-treated with RA 
until 20s stage exhibited defects in endocardial cushion formation at 52 hpf. Tg[fli1:EGFP] 
embryos co-treated with ethanol and RA (2 hpf to 20s) displayed little or no clustering of 
GFP and F-actin positive cells at the AV boundary, which were instead dispersed throughout 
the ventricle (Fig. 7H). To determine whether RA supplementation could rescue cardiac 
defects caused by ethanol exposure during cardiac patterning, embryos were co-treated with 
ethanol and RA from 20s until 36 hpf (Fig. 7I). Examining cardiac looping in 
Tg[cmlc2:GFP] embryos at 36 hpf showed significant rescue after RA supplement (Fig. 7J, 
K). Interestingly, endocardial cushion cells showed a dispersed pattern in ethanol plus RA 
treated (20s until 36 hpf) Tg[fli1:EGFP] embryos at 52 hpf (Fig. 7L). These findings 
provide evidence that RA supplement could restore ethanol-induced defects of gene 
expression during specification, heart cone formation, and cardiac looping but not the 
endocardial cushion formation defect.
Folic acid supplementation prevents ethanol-induced heart defects more effectively than 
RA
FA supplementation was tested for rescue of ethanol-induced ethanol-induced cardiac 
defects in zebrafish. Co-treating zebrafish embryos with 50 μM FA and ethanol during entire 
cardiogenesis (2 to 48 hpf) partially rescued cardiac edema, but co-treatment with 75 μM FA 
(2 to 48 hpf) significantly rescued cardiac edema, small eye, and body length defects seen in 
embryos exposed to ethanol alone (Fig. 8A, B). Ethanol and FA co-treated Tg[cmlc2:GFP] 
and embryos showed normal heart tube at 24 hpf (Fig. 8C). At 52 hpf, ethanol and FA co-
supplemented embryos exhibited near normal myocardium morphology (Fig. 8D; Supp. 
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Movies S1, S2 and S5). Tg[fli1:EGFP] embryos co-supplemented with ethanol and FA 
showed normal endocardium formation at 28 hpf and 52 hpf (Fig. 8E, F). GFP and F-actin 
positive endocardial cushion cells were rescued by co-treatment of FA with ethanol in Texas 
red-phalloidin stained Tg[fli1:EGFP] embryos (Fig. 9B–G). Alcam-stained FA and ethanol 
co-treated Tg[cmlc2:GFP] embryos showed region specific cardiomyocyte shape (Mean 
surface area, OC: E-100+FA, 117±27 μm2; E-150+FA, 120±21 μm2; IC: E-100+FA, 61±10 
μm2; E-150+FA, 62±14 μm2), restoring ventricular wall morphology (Fig. 9H–M). Unlike 
RA, FA supplementation was able to significantly prevent cardiac defects in embryos, even 
when exposed to stringent, chronic ethanol exposure regimen (Fig. 9N). These findings 
showed that FA is a better supplement than RA that rescued a more complete spectrum of 
cardiac defects including endocardial cushion defect, in addition to other ethanol-induced 
defects.
DISCUSSION
Our experiments demonstrated that ethanol exposed zebrafish embryos exhibit cardiac 
defects including valve formation defects. This study differs from previous studies of animal 
models in various ways. First, we examined a chronic alcohol exposure model, exposing 
embryos during all cardiogenesis stages. Second, we analyzed ethanol effects on both 
myocardium and the previously unexplored endocardium development in live embryos. 
Third, we used acute ethanol exposure regimens to target different heart development stages: 
i) gastrulation through cardiac specification; ii) gastrulation through myocardiocyte midline 
fusion; iii) cardiac patterning; and iv) cardiac growth. For the above time periods, we 
systematically analyzed acute effects of ethanol exposure, and the persistence of these 
cellular and molecular effects in hearts at later larval stages. Our results support the idea that 
the wide varieties of FASD-associated CHDs reflect differences in ethanol dosage and 
exposure timing during heart development.
Ethanol exposure alters multiple steps of cardiogenesis
Ethanol interrupts multiple cardiogenesis events (specification, myocardial migration, 
looping, chamber morphogenesis and endocardial cushion formation). Perturbation of 
multiple/regulatory networks solely by ethanol epitomizes the complexity of FASD 
phenotypes and suggests that a single mechanism alone cannot explain the entire spectrum 
of ethanol-induced cardiac defects. Ethanol treatment did not randomize left-right heart 
asymmetry. Although critical cardiac development events were sensitive to ethanol, short 
exposure windows only during cardiac specification or only during myocardial migration 
did not produce severe or persistent heart development defects. Zebrafish embryos possess 
sufficient plasticity to recover from these developmental delays and produce a relatively 
normal embryo. An ethanol exposure window from gastrulation until myocardial migration 
caused heart defects including endocardial cushion defects that persist into later larval 
stages, suggesting that combined effects on these stages are responsible for the most severe 
phenotypes. Ethanol exposure during cardiac patterning stage (20s to 36 hpf) produced 
similar cardiac phenotypes as those produced by ethanol exposure from gastrulation until 
myocardial migration stages. How did ethanol exposure at different heart development 
stages produce similar heart phenotypes? Cardiac development requires multiple progenitor 
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cell types: first heart field, second heart field, and cardiac neural crest cells (Lin, C, 2012). 
These progenitors are derived in different locations in the embryo and are incorporated into 
the heart at different developmental stages. Ethanol exposure at different heart development 
stages might affect various progenitor cell types differentially. Future study is needed to 
better understand ethanol effect on different cardiac progenitors including their 
incorporation into the heart.
Chronic alcoholism and cardiac defects
Our study demonstrated that chronic ethanol exposure produced more complex phenotypes 
than ethanol exposure at a specific heart development stage. Chronic exposure produced 
straight heart that appeared smaller and very defective ventricle with double lobes. 
However, there was no internal tissue detected that separated the ventricular chamber as 
indicated by confocal optical sections of TO-PRO 3 stained Tg[cmlc2:GFP]embryos and 
actin stained Tg[fli1:EGFP] embryos.
Our study showed previously unappreciated effects of ethanol on ventricle chamber 
regionally confined cardiomyocyte shape changes. Smaller ventricle is because of reduced 
cardiomyocyte number and cardiomyocyte size. Endocardial cushion defects caused by 
chronic ethanol exposure (2–48 hpf) were more severe than defects seen after short ethanol 
exposure (2 hpf–20s or 20s–36 hpf). Chronic exposure almost completely eliminated 
endocardial cushion cells. In contrast, short exposures had a less severe phenotype, showing 
differentiated endocardial cells that are not at the AV boundary, but are instead dispersed 
throughout ventricle. Chronic alcohol consumption during pregnancy in humans may affect 
multiple steps of heart development, leading to complex cardiac defects (showing more than 
one congenital heart defect). Complex cardiac defects were common among offspring of 
chronic alcoholic mothers (Strandberg-Larsen et al., 2011).
Possible mechanisms of ethanol-induced cardiac defects
Numerous potential mechanisms were previously proposed to explain ethanol effects on the 
developing embryo, for example: 1) Changes in gene expression including retinoic acid 
signaling activity; 2) Increased oxidative stress-excess free radical and reduced antioxidant 
level; 3) Changes in cell adhesion; 4) Increased cellular apoptosis; and 5) Disrupted cellular 
metabolism (Abel, 1998; Mitchell et al., 1999). Our chronic vs. acute ethanol exposure 
analysis supports the idea that multiple mechanisms may act concurrently or consecutively, 
and thus, severity of ethanol-induced defects could vary due to developmental stage, dosage 
and duration. For example, ethanol exposure during cardiac looping (20s to 36 hpf) did not 
produce straight heart, but this treatment reduced the extent of cardiac looping. On the other 
hand, chronic exposure more completely blocked the looping process, producing straight 
heart. Similarly, ethanol exposure during the chamber cardiomyocyte shape change period 
(from 40–56 hpf) did not affect the regionally confined cell shape changes, but chronic 
exposure persistently affected this event. Together, these findings support a model that 
consecutive detrimental effects on multiple developmental events and mechanisms cause 
ethanol-induced heart defects.
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During cardiogenesis, ethanol could affect various dynamic processes. Directional cell 
migration defects may participate in ethanol-induced cardiac specification and myocardial 
migration defects. Studies showed that ethanol interfered with convergence extension 
movements during early development (Yelin et al., 2005; Zhang et al., 2010). Reduced 
directional cardiac precursor migration probably expands the heart field region, resulting in 
their dispersion in a larger area of ALPM. Myocardial migration to the midline and 
subsequent rotation to form a linear tube was defective after ethanol exposure as observed in 
live Tg[cmlc2:GFP] embryos by time lapse imaging (SS and JAM, unpublished data). 
Developmental delay could also disrupt normal tissue interactions, causing ethanol-induced 
malformations. Interestingly, the rate of ethanol-induced developmental delay was not 
uniform throughout the embryo, but varied from organ to organ. Somite development was 
relatively faster than cardiac cone formation. Control embryos reached 20s at 19 hpf, but 
100 mM ethanol treated embryos reached 20s almost half an hour later, at around 19.5 hpf. 
Cardiac cone was formed at 19 hpf (20s) in the control embryos. In 100 mM ethanol 
exposed embryos, cardiac cone started to form at around 23 hpf, at 25s stage. These 
developmental delays could produce asynchronous morphogenesis and tissue interaction 
events. For example, some ethanol treated embryos showed cardiomyocyte rotation prior to 
their proper fusion at the midline, leading to cardia bifida. Endocardial cushion formation 
was the most ethanol sensitive event detected in our study. Endocardial cushion originates 
from three different progenitor populations in mammals: endocardial; SHF; and cardiac 
neural crest cells (Lin et al., 2012). Our study demonstrated that ethanol exposure caused 
defective endocardium morphogenesis in zebrafish that could lead to the endocardial 
cushion defect. Ethanol exposure reduced the expression of Islet 1, a marker for SHF 
(Serrano et al., 2010). Future study is needed to examine potential effects of ethanol on 
different progenitor populations.
Retinoic acid and folic acid protection
Our study demonstrated that RA co-supplement for short durations was able to partially 
rescue ethanol-induced cardiac specification, migration, and looping defects. RA 
supplement during cardiac specification restored the nkx2.5 expression pattern in the cardiac 
field. RA signaling from the developing somites restricts posterior boundary of the cardiac 
field during specification. Weak RA signaling presumably led to the expansion of nkx2.5 
expression antero-posteriorly, and thus, providing RA exogenously at this stage helped 
restore normal nkx2.5 expression patterns. RA signaling is also necessary for cardiac 
looping. RA deficient Raldh2−/− knockout mouse embryos failed to undergo heart looping 
(Niederreither et al., 2001). Reduced RA might have caused reduced cardiac looping in the 
embryos exposed to ethanol, and exogenous RA supply from 20s–36hpf period helped 
restore normal cardiac looping. However, continuous exogenous supply of RA was not very 
effective in preventing chronic ethanol exposure associated heart defects, but RA was able 
to rescue some other ethanol-induced defects such as small eye and short body. Endocardial 
cushions defects caused by ethanol exposure could not be rescued by 1 nM RA supplement. 
It may be possible that treatment with different RA concentrations during endocardial 
cushion formation period would rescue this defect, but this has not been analyzed.
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Maternal FA deficiency is associated with neural tube and congenital heart defects. FA 
supplementation reduces the risk of these defects, although the biological mechanisms for 
folate mediated birth defect reduction are unknown (Bean et al., 2011). Epidemiological 
studies showed that FA supplementation prevented cardiac defects (Bailey and Berry, 2005; 
Ionescu-Ittu et al., 2009). A recent study demonstrated that human and zebrafish utilize 
similar one-carbon pathways, and folate metabolism is essential for early zebrafish 
development including heart (Lee et al., 2012). Our study demonstrated that cardiac defects 
in zebrafish caused by chronic ethanol exposure, which affects multiple steps of 
cardiogenesis, could be prevented by FA supplementation. Although the specific molecular 
mechanisms remain to be defined, it seems reasonable to speculate that FA protects the 
embryos from ethanol-induced defects by epigenetic mechanisms. It was reported that 
alcohol exposure changes the DNA methylation pattern and causes epigenetic changes 
(Ballard et al., 2012; Garro et al., 1991; Kaminen-Ahola et al., 2010; Liu et al., 2009; Zhou 
et al., 2011b). FA is required for the production of methyl groups, which are subsequently 
used to methylate DNA during epigenetic events. FA also has antioxidant properties 
(Ibrahim et al., 2012; Joshi et al., 2001) and might attenuate the ethanol-induced oxidative 
stress. The diverse effects of ethanol on zebrafish embryo development and the extensive 
rescue by FA co-supplementation suggest that a global development regulatory mechanism 
affects various developmental events.
Cardiac defects caused by ethanol treatment during gastrulation, and their prevention by 
folate supplement, was reported in mice and chick models (Serrano et al., 2010). Our study 
demonstrated that myocardium and endocardium defects caused by prolonged ethanol 
exposure in zebrafish could be attenuated by FA supplementation, strongly supporting the 
hypothesis that folate supplementation prevents a large spectrum of CHDs in FASD.
CONCLUSIONS
This is the first study showing ethanol effects on distinct cardiogenic events and the effect of 
exposure timing on the persistence of heart defects at larval stages. Our data showed that 
ethanol exposure interrupted divergent cardiac morphogenesis events, causing heart defects. 
Additionally, prevention of these defects by retinoic acid or folic acid co-supplementation 
indicates that these nutritional compounds could mitigate FASD-like defects. Altogether, 
this study illustrates the complexity of FASD phenotypes and indicates that a single 
mechanism alone does not explain the entire spectrum of ethanol-induced cardiac defects. 
Future studies are needed to analyze ethanol effects on different cardiac progenitor 
populations, which will help elucidate the mechanistic details of FASD-associated heart 
defects.
EXPERIMENTAL PROCEDURES
Zebrafish husbandry
Zebrafish (Danio rerio; TL and AB strains; Tg[cmlc2:GFP] and Tg[fli1:EGFP] transgenic 
lines) were raised and housed under standard laboratory conditions (Westerfield, 2000), in 
accordance with Indiana University Policy on Animal Care and Use.
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Ethanol, retinoic acid, and folic acid treatment
Zebrafish embryos were exposed to two different concentrations of ethanol: 100 mM (0.6% 
v/v) or 150 mM (0.9% v/v), at various developmental stages. 100 mM was the lowest 
concentration that consistently produced embryos featuring FASD-like phenotype including 
short body, small head circumference and small eyes. Actual ethanol concentrations within 
tissues of treated embryos were not measured. RA (Sigma, all trans retinoic acid) 
concentration was used as described previously (Marrs et al., 2010). This concentration 
showed no RA induced defects in zebrafish. Different FA (Sigma, F7876-1G) 
concentrations (10−7 M–10−5M) were tested for their ability to consistently rescue ethanol-
induced defects. 50 μM FA was the lowest concentration tested that partially rescued 
ethanol-induced defects. Concentration higher than 75 μM FA could not be tested because 
FA precipitated out of embryo medium (EM).
For chronic exposure, embryos were maintained in embryo medium until 2 hpf. At this time, 
embryos were transferred to one of the following conditions: EM (control); EM containing 
ethanol (100 mM or 150 mM); EM containing ethanol and 1 nM RA; EM containing ethanol 
and 75 μM FA; EM containing 1 nM RA; and EM containing 75 μM FA. Petri dishes 
containing embryos were wrapped with parafilm and maintained at 28.5°C. At 24 hpf, 
respective solutions were replaced with fresh treatment solutions. Embryos were replaced 
with EM without additions at 48 hpf and examined at various times.
For short exposures, embryos were treated during examined heart development stages with 
the above solutions, and examined at various times. Embryos were in EM before or after 
treatment. When needed, embryos were treated with 1-phenyl 2-thiourea (0.003% ) to 
prevent melanogenesis.
Microscopy
Differential interference contrast images of live embryos were collected using a Zeiss 
Observer Z1 (20X 0.8 NA objective) equipped with an Orca-AG CCD camera (Hamamatsu 
Photonics). Brightfield images were digitally acquired with a color Leica DFC290 camera 
mounted on a Leica MZ12 dissecting stereomicroscope (Leica Microsystems, Inc.). Images 
were also acquired using a Zeiss Observer Z1 LSM 700 confocal microscope (40X 1.1 NA 
W or 20X 0.8 NA objectives). 3D renderings and Supplementary Movies were produced 
from images volumes using Volocity software (PerkinElmer/Invitrogen).
Immunofluorescence and F-actin staining
Whole-mount immunostaining was performed as previously described (Clendenon et al., 
2012) using primary antibody against alcam (Zn5; ZIRC) at a dilution of 1:250. Texas red-
conjugated anti-mouse secondary antibody was used at a 1:100 dilution (Molecular probes/
Invitrogen). Texas red-conjugated phalloidin (Molecular Probes/Invitrogen) was used at a 
1:100 dilution.
Cell counting and cell surface measurement
Alcam stained Tg[cmlc2:GFP] embryos were imaged with Zeiss Observer Z1 LSM 700 
confocal microscope. Ventricular cardiomyocytes were counted using Volocity software 3D 
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opacity view. Cells in the extended focus images were outlined and surface area of 
ventricular cardiomyocytes was measured using Volocity software.
In situ hybridization
Whole-mount in situ hybridization of zebrafish embryos was performed as described 
(Sarmah et al., 2010). Digoxigenin-labeled riboprobes for cmlc2, vmhc, bmp4, nkx2.5, gata5 
and fgf8 (generously provided by Drs. Ela W. Knapik and Jau-Nian Chen) were synthesized 
using DIG RNA Labeling Kit (Roche).
Quantitative PCR Analysis
Total RNA was extracted from the whole embryo (~ 20 embryos) at 6s or 12s stages using 
the TRIzol reagent (Sigma). One microgram of total RNA was reverse transcribed to cDNA 
using M-MLV reverse transcriptase (Promega), and cDNA was diluted tenfold with RNase 
free water. Each PCR reaction was performed with 1–4 μl of cDNA using Power SYBR 
Green PCR mix (Applied Biosystems) and 0.5 μM of each primer. Primer sets used are: 
hand2-f: GAGTTTAGTTGGAGGGTTTCCCCACC; hand2-r: 
GTAGTGCGAATGGTCGAGCCCG; fgf8-f1: ACGGACACATTTGGGAGTCGAGTT; 
fgf8-r1:TCACATTCTGCAGAGCCGTGTAGT; gata5-f1: 
TTCTCTTATTCGCACAGTCCGCCA; gata5-r1: AGGGCACTTCCATATTGATCCGCA; 
nkx2.5-f1: TGGGAGACACGTCCACTTACAACA; nkx2.5-
r1:TGCTCGACGGATAGTTGCATGAGT; tbx5a-f1: 
CAGACAAACAGAATGCAGCCGTCA; tbx5a-r1: 
ACTTTGAAGCTGGGAAACATCCGC; rsp15-f: CAGAGGTGTGGACCTGGACCAGC; 
rsp15-r: CGGGCAGGATGACCATGTCTCTC. Three independent experiments in triplicate 
were performed using rsp15 as internal control. Thermal cycling was carried out either 7300 
Real Time PCR System (Applied Biosystems) or LightCycler 480 (Roche).
Statistical Analysis
Statistical analyses were performed using paired two-tailed Student’s t-test (GraphPad 
Software) or Mantel-Haenszel chi-square test (Biostatistics services, IUSM).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Zebrafish FASD model showed that ethanol interrupts multiple steps of 
cardiogenesis.
• Ethanol exposure during zebrafish cardiogenesis produces persistent heart 
defect.
• Chronic ethanol exposure during cardiogenesis produces complex cardiac 
defects.
• Retinoic acid co-supplementation partially rescues ethanol induced cardiac 
defect.
• Folic acid co-supplementation prevents wide spectrum of ethanol-induced heart 
defects.
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Figure 1. Chronic ethanol exposure during cardiogenesis severely disrupts heart formation
(A) Schematic diagram showing the developmental timing (2–48 hpf) of ethanol exposure. 
(B, C) Live images showed pericardial edema (arrows) (B), and smaller, misshapen 
chambers with aberrant AV canal (arrowheads) in the ethanol treated embryos (C). (D, G) 
3D renderings of confocal sections of Tg[cmlc2:GFP] and Tg[fli1:EGFP] embryos showing 
distorted myocardium, multilobed ventricle (D), and misshapen endocardium (G) in ethanol 
exposed embryos. Yellow arrowheads: multiple lobes. (E, F) Single confocal sections at the 
AV boundary of alcam-stained Tg[cmlc2:GFP] embryos showing a single ventricle in the 
control and two ventricular lobes (1 & 2) in the ethanol treated embryo. White arrows: 
abnormal additional ventricular wall connection. (H) Confocal images of Texas red-
phalloidin stained Tg[fli1:EGFP] embryos showing defective endocardium corresponding to 
the myocardium in ethanol exposed embryos. (I, J) Brightfield live images of 
Tg[cmlc2:GFP] embryos showed abnormal heart (I) and blood clot (J; blue arrow) at 96 hpf 
in ethanol exposed embryos. (K) Scores showing the effect of ethanol on cardiac 
development (Results from three individual experiments). Mantel-Haenszel chi-square 
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tests:PE, P<0.0001; looping defect, P<0.0001; ventricular wall defect, P<0.0001. a, atrium; 
v, ventricle. Anterior to the left (B–H, J), anterior to the top (I).
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Figure 2. Chronic ethanol exposure during cardiogenesis produces defective chambers and 
endocardial cushion
(A) Schematic diagram showing the developmental timing (2–48 hpf) of ethanol exposure. 
(B–D) Ethanol treated embryos do not have stereotypical regionally confined cardiomyocyte 
shapes. Extended focus images of confocal sections from control Tg[cmlc2:GFP] embryo 
(B) costained with alcam antibody showed large, elongated cardiomyocytes in the outer 
curvature (OC) and AV region, and small rounded cardiomyocyte in the inner curvature (IC) 
of the ventriclular surface in control embryos; the orientation of the cells were aligned with 
each other. (C) Cardiomyocytes were disorganized, showing variable sizes and shapes in 
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ethanol treated embryos. (D) Ethanol treatment occasionally caused cardia bifida, which 
display small cardiomyocytes. Representative cell shapes are highlighted in yellow; white 
arrowhead: abnormal thin cell. (E–G) Severely defective endocardial cushion formation was 
seen after ethanol treatment. (E) Confocal sections of the control 52 hpf Tg[fli1:EGFP] 
embryo heart co-labeled with Texas red-phalloidin (F-actin), showed clusters of GFP and F-
actin positive cells (white dotted line) at the AV boundary, which were reduced (F) or absent 
(G) in ethanol treated embryos. A: anterior, P: posterior, a: atrium, v: ventricle.
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Figure 3. Ethanol exposure during gastrulation through cardiac specification induces defects in 
cardiac gene expression and myocardial migration
(A) Schematic diagram shows the timing of ethanol exposure. (B–D) Whole mount ISH at 
13s stages showed moderate expansion of expression domains for nkx2.5 (B) (see figure 7C 
for statistical significance), gata5 (C), and fgf8a (D) in the ethanol treated embryos, as 
compared to control. (E) Transcript levels of genes expressed in differentiating myocardial 
cells increased after ethanol treatment. Quantitative RT-PCR assays comparing cardiogenic 
gene expression levels at 6s and 12s stages (average fold change from at least 3 independent 
experiments), Student’s t-test: *P<0.01. (F) ISH detecting cmlc2 at 20s stage showed cardiac 
fusion delay after ethanol treatment (2 hpf–12s). (G) Live images of Tg[cmlc2:GFP] 
embryos exposed to ethanol (2 hpf–12s) showed normal cardiac looping and normal 
chamber morphology. (H) bmp4 expression examined by ISH. Ethanol exposed (2 hpf–12s) 
embryos showed normal bmp4 expression pattern. Arrowheads: AV boundary; arrows: OFT; 
dotted line: cardiac silhouette. (I) Graph illustrates myocardial fusion differences at 20s 
Sarmah and Marrs Page 24
Dev Dyn. Author manuscript; available in PMC 2014 December 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
stage in control and ethanol treated embryos. Mantel-Haenszel chi-square tests: P<0.0001 
for both control vs. EtOH-100 and control vs. EtOH-150. n: number of embryos. A: anterior, 
P: posterior.
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Figure 4. Ethanol exposure until cardiac fusion produces defects that persist at later stages of 
development
(A, N) Schematic diagrams showing the timing of ethanol exposure. (B–D) ISH of cmlc2 
expression at 19s and 25s; vmhc expression at 25s showed delay in myocardial fusion in 
ethanol exposed embryos. Arrows: posterior fusion. (E, E′) bmp4 expression at 20 hpf. (E) 
Control, (E′) ethanol exposed embryos. Arrow: cardiac primordium; arrowhead: posterior 
retina. (F–F‴) bmp4 expression at 25hpf. (F) Control, (F′–F‴) representatives of ethanol 
exposed embryos. (G, H) Tg[fli1:EGFP] embryo images at 20s (G) and 24 hpf (H) stages 
showed defective endocardium formation after ethanol exposure. (I) Tg[cmlc2:GFP] 
embryo images showed aberrant looping angle. (J) Graph shows quantification of looping 
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angle. (K) bmp4 expression in the control and ethanol exposed embryos at 48 hpf. 
Arrowhead: AV boundary; arrow: OFT. (L, M) Stained Tg[fli1:EGFP] embryos showed 
dispersion of GFP and F-actin positive cells (white brackets) throughout the ventricle after 
ethanol exposure. (N–R) Ethanol exposure only during myocardial migration (12s–20s) 
causes modest fusion delay. (O–Q) ISH showed cmlc2 expression. (O) Control, (P,Q) 
ethanol exposed embryos. (R) Graph shows quantification of myocardial precursors fusion. 
(P-value: Mantel-Haenszel chi-square tests). A: anterior, P: posterior.
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Figure 5. Ethanol exposure during cardiac looping caused abnormal heart morphogenesis and 
defective endocardial cushions
(A, G) Schematic diagram showing ethanol exposure timing. (B) ISH detecting cmlc2 at 36 
hpf: control, normal looping; EtOH-100 mM, modest looping; EtOH-150 mM, straight heart 
tube. (C) Graph quantifies looped and straight heart at 36 hpf. (D) 3D confocal images of 
Tg[cmlc2:GFP] embryos: control, normal heart chambers; ethanol treated embryos, aberrant 
heart chambers. Yellow asterisks: AV canal. (E) Ethanol treated Tg[fli1:EGFP] embryos 
showed dispersed GFP and F-actin positive cells (white dashed line) throughout the 
ventricle (compare control panel 2E). (F) Alcam stained Tg[cmlc2:GFP] embryo showed 
similar distribution of cardiomyocytes in the control and ethanol treated embryos. (G–I) 
Ethanol exposure during cardiac chamber morphogenesis did not lead to defective chamber 
wall formation. (H) 3D confocal images of Tg[cmlc2:GFP] embryos: control and E-100 
mM, normal heart; E-150, nearly normal heart chamber. Yellow brackets: AV region. (I) 
Alcam stained Tg[cmlc2:GFP] embryos showed similar pattern of cardiomyocyte 
distribution in the ventricular wall in ethanol treated and control embryos. White asterisk: 
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alcam positive hatching gland cells, which are outside the heart but seen in this 3D 
rendering. Representative cell shapes are highlighted in yellow. Anterior to the top.
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Figure 6. RA Supplementation during chronic ethanol treatment (2–48hpf) does not restore 
normal heart development
(A) Schematic diagram showing the timing of ethanol and RA exposure. (B–M) Live images 
of embryos at 28 (B–G) and 52 hpf (H–M) showed normal morphology in the control (B, H) 
and RA treated (E, K) embryos. Ethanol treated embryos exhibited small eye, shorter body 
(C, D, I, J) and pericardial edema (I, J). Ethanol+RA treated embryos showed near normal 
eye size, slightly shorter body (F, G, L, M) and pericardial edema (L, M). Arrows: black, 
posterior end of the embryos; white: eye; arrowhead: pericardial edema. (N–S) 3D 
renderings of fixed Tg[cmlc2:GFP] embryo confocal sections showed normal cardiac 
morphology in control (N) and RA treated embryos (Q); straight hearts in ethanol treated 
embryos (O, P); near normal or straight heart in ethanol+RA cotreated (R, S) embryos. (T, 
Y) Phalloidin stained Tg[fli1:EGFP] embryos: clustering of GFP/F-actin positive cells 
(white dashed line) at the AV boundary in the control (T) and RA treated embryos (W); 
reduction and dispersion of GFP/F-actin positive cells in ethanol treated embryos (U, V); 
dispersion of GFP/F-actin positive cells throughout the ventricle in ethanol+RA cotreated 
embryos (X, Y). A, anterior; P, posterior.
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Figure 7. RA supplementation during acute ethanol treatment partially rescues a subset of 
cardiac development defect
(A, E, I) Schematic diagrams showing the timing of ethanol and RA exposure. (B) ISH 
showed nkx2.5 expression in the control, ethanol, RA, and ethanol+RA treated embryos 
(2hpf–12s). (C) Graph shows the quantification of nkx2.5 expressing domain length after 
ethanol exposure (2hpf–12s). (D) Graph shows quantification of myocardial fusion at 20s 
after ethanol exposure (2hpf–12s). (F) Expression of cmlc2 in the control, ethanol, RA, and 
ethanol+RA treated embryos (2hpf–20s). (G) Graph shows the quantification of myocardial 
fusion. (H) Stained Tg[fli1:EGFP] embryos showed the dispersion of GFP and F-actin 
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positive cells (white dashed line) throughout the ventricle in the ethanol and ethanol+RA 
cotreated embryos (2hpf–20s). (J) Brightfield images of Tg[cmlc2:GFP] embryos showed 
hearts of control, ethanol, RA, and ethanol+RA treated (20s–36hpf) embryos. (K) Graph 
showing the quantification of looped and straight heart (as in E-150) at 36 hpf (L) Stained 
Tg[fli1:EGFP] embryos showed reduced clustering of GFP, F-actin double positive cells 
near the AV boundary in ethanol+RA treated (20s–36 hpf) embryos (Compare control panel 
7H; ethanol 5E). Statistical analyses: C, Student’s t-tests; D, G, K, Mantel-Haenszel chi-
square tests.
Sarmah and Marrs Page 32
Dev Dyn. Author manuscript; available in PMC 2014 December 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 8. FA supplementation during chronic ethanol exposure (2–48hpf) rescues ethanol-
induced cardiac defects
(A) Schematic diagram showing the timing of ethanol and FA exposure. (B) Live images 
showed heart edema, small eye, and short body length in the ethanol exposed embryos and 
normal morphology in FA cosupplemented (2–48hpf) embryos. Arrow: black, heart; white: 
eye; arrowhead: posterior end of the embryo. (C, D) Confocal images of Tg[cmlc2:GFP] 
embryos showed linear heart tube (24 hpf) and normal chambers (52 hpf) in the control, FA 
treated, and ethanol+FA cotreated embryos. Ethanol exposed embryos exhibited abnormal 
heart tube with defective myocardial fusion (asterisk, 24 hpf) and misshapen hearts (52 hpf). 
(E, F) Confocal images of Tg[fli1:EGFP] at 28 and 52 hpf showed misshapen endocardium 
(yellow arrows; e, eye) in the ethanol treated; normal endocardium in control, FA treated, 
and E-100+FA cotreated; and near normal endocardium in E-150+FA cotreated embryos. 
(G) Scores showing the effect of continuous supplement of RA or FA with ethanol on 
pericardial edema (PE). Results shown were calculated from three individual experiments. 
(Mantel-Haenszel chi-square tests: control vs. EtOH-100 or EtOH-150, P<0.0001; control 
vs. RA, P=1.00; EtOH-150 vs. EtOH-150+RA, P<0.0001 (*); control vs. FA, 
P=0.01;EtOH-100 vs. EtOH-100+FA, P<0.0001 (#); EtOH-150 vs. EtOH-150+FA, 
P<0.0001 ($)).
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Figure 9. Folic acid supplementation during chronic ethanol exposure (2–48 hpf) rescues 
ethanol-induced endocardial cushion and chamber formation defects
(A) Schematic diagram showing the timing of ethanol and FA exposure. (B–G) Endocardial 
cushion formation was restored in ethanol exposed, FA co-supplemented embryos. Stained 
Tg[fli1:EGFP] embryos showed clustering of GFP and F-actin positive cells (white dashed 
line) in the control, FA treated, and ethanol+FA co-treated embryos. Ethanol treated 
embryos exhibited no clustering of GFP and F-actin positive cells at the AV boundary. 
White arrow: defective wall in the ventricle. a, atrium; v, ventricle. Atrium in the ethanol 
treated embryos cannot be seen in this view. (H–M) Ethanol-induced ventricular chamber 
defects were rescued in the FA cosupplemented embryos. Alcam stained Tg[cmlc2:GFP] 
embryos showed similar pattern of cardiomyocyte distribution in the ventricular wall of 
control, FA treated, and ethanol+FA cotreated embryos; cardiomyocyte sizes and shapes 
were variable throughout the ventricular wall in the ethanol treated embryos. Inset in 150 
mM ethanol showed cardia bifida. Anterior to the top.
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